Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CDMO

Avid Bioservices Inc

Dec 10 • 04:00PM ET

12.31

Dollar change +0.04
Percentage change 0.33	%

Healthcare • Biotechnology • USA • NASD

Peers: REGN AMGN VRTX BMRN GILD BIIB INCY PCRX NBIX UTHR

| Held by: IWM VTI XBI VXF IWO DWAS SCHA VTWO VHT MNA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.27	Insider Own	1.17%	Shs Outstand	63.96M	Perf Week	-0.08%
Market Cap	787.30M	Forward P/E	-	EPS next Y	-0.07	Insider Trans	-4.11%	Shs Float	63.21M	Perf Month	0.41%
Income	-152.04M	PEG	-	EPS next Q	-0.06	Inst Own	101.51%	Short Float	18.41%	Perf Quarter	16.13%
Sales	150.46M	P/S	5.23	EPS this Y	86.77%	Inst Trans	2.65%	Short Ratio	6.23	Perf Half Y	54.07%
Book/sh	0.92	P/B	13.39	EPS next Y	76.27%	ROA	-37.08%	Short Interest	11.64M	Perf Year	165.30%
Cash/sh	0.52	P/C	23.57	EPS next 5Y	15.00%	ROE	-115.84%	52W Range	4.50 - 12.48	Perf YTD	89.38%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-66.86%	ROI	-57.77%	52W High	-1.36%	Beta	1.41
Dividend TTM	-	Quick Ratio	1.05	Sales past 5Y	23.05%	Gross Margin	5.94%	52W Low	173.56%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	1.46	EPS Y/Y TTM	-4052.47%	Oper. Margin	10.07%	RSI (14)	67.83	Volatility	0.70% 0.92%
Employees	371	Debt/Eq	3.54	Sales Y/Y TTM	6.76%	Profit Margin	-101.05%	Recom	2.60	Target Price	12.88
Option/Short	Yes / Yes	LT Debt/Eq	3.49	EPS Q/Q	-	Payout	-	Rel Volume	0.25	Prev Close	12.27
Sales Surprise	-0.89%	EPS Surprise	-129.79%	Sales Q/Q	31.92%	Earnings	Dec 10 AMC	Avg Volume	1.87M	Price	12.31
SMA20	0.50%	SMA50	9.76%	SMA200	33.23%	Trades		Volume	464,891	Change	0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-28-23	Initiated	William Blair	Mkt Perform
Mar-14-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$20
Dec-08-21	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-17-21	Initiated	RBC Capital Mkts	Outperform	$21
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$12
Dec-10-19	Upgrade	First Analysis Sec	Outperform → Strong Buy
Oct-17-19	Initiated	Stephens	Overweight	$8
Oct-16-19	Initiated	Craig Hallum	Buy	$11
Jun-28-19	Upgrade	Janney	Neutral → Buy	$10
May-09-19	Downgrade	Janney	Buy → Neutral

Today 05:03AM	Avid Bioservices: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
Dec-10-24 04:05PM	Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024 (GlobeNewswire)
Nov-17-24 04:52PM	Avid Bioservices, Inc. (CDMO): A Bull Case Theory (Insider Monkey)
Nov-08-24 06:37AM	Avid Bioservices to be Acquired in $1.1 Billion Deal (TipRanks)
Nov-07-24 06:59AM	GHO and Ampersand Capital to acquire Avid Bioservices (Pharmaceutical Technology) +11.48%
06:44PM	Loading…
Nov-06-24 06:44PM	Avid Bioservices to Go Private in $1.1 Billion Deal (The Wall Street Journal)
06:04PM	Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction (GlobeNewswire)
Oct-17-24 03:03PM	State Street Corp's Strategic Reduction in Avid Bioservices Inc Holdings (GuruFocus.com)
Sep-12-24 04:05PM	Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference (GlobeNewswire) +5.28%
Sep-10-24 06:59AM	Q1 2025 Avid Bioservices Inc Earnings Call (Thomson Reuters StreetEvents) +17.21%
Sep-09-24 04:19PM	Avid Bioservices: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 (GlobeNewswire)
Sep-06-24 09:01AM	What To Expect From Avid Bioservices Inc (CDMO) Q1 2025 Earnings (GuruFocus.com)
Sep-05-24 12:02AM	Avid Bioservices, Inc. (CDMO): This Small-Cap Healthcare Stock Is A Good Buy Right Now (Insider Monkey)
Sep-03-24 04:05PM	Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 (GlobeNewswire) -7.69% -5.04%
05:22PM	Loading…
Sep-02-24 05:22PM	10 Best Small-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Jul-26-24 01:37AM	Does Avid Bioservices (CDMO) have Hidden Potential Despite Current Weakness? (Insider Monkey)
Jul-03-24 08:02AM	Avid Bioservices, Inc. (NASDAQ:CDMO) Q4 2024 Earnings Call Transcript (Insider Monkey) +14.93%
Jul-02-24 08:53PM	CDMO Stock Earnings: Avid Bioservices Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace) -5.90%
04:05PM	Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 (GlobeNewswire)
Jul-01-24 07:00AM	Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 (GlobeNewswire)
Jun-11-24 01:13PM	Halozyme Therapeutics, Inc. (NASDAQ:HALO) Downgraded by Piper Sandler (Insider Monkey)
May-23-24 08:05AM	Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance (GlobeNewswire)
May-08-24 12:26PM	Hidden Gems: Unveiling the 10 Stocks on Hedge Funds' Radar (Insider Monkey)
May-07-24 04:05PM	Avid Bioservices to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-03-24 04:17AM	How Novo-Catalent Deal Affects Halozyme (HALO)? (Insider Monkey)
03:31AM	Do You Believe in the Upside Trajectory of Avid Bioservices (CDMO)? (Insider Monkey)
02:44AM	Here's Why Laughing Water Capital Invested in Lifecore Biomedical (LFCR) (Insider Monkey)
Apr-30-24 06:48AM	Q3 2024 Avid Bioservices Inc Earnings Call (Thomson Reuters StreetEvents)
03:05AM	Avid Bioservices Inc (CDMO) Q3 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
02:46PM	Loading…
Apr-25-24 02:46PM	Avid Bioservices (CDMO) Quantifies Wrongful Accounting Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities Hagens Berman (GlobeNewswire) +7.17%
Apr-24-24 10:52PM	CDMO Stock Earnings: Avid Bioservices Misses EPS, Beats Revenue for Q3 2024 (InvestorPlace)
05:39PM	Avid Bioservices: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
05:25PM	Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 (GlobeNewswire)
Apr-10-24 12:46PM	Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities Hagens Berman (GlobeNewswire)
Apr-01-24 03:07PM	Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities Hagens Berman (GlobeNewswire)
Mar-28-24 12:51PM	Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities Hagens Berman (GlobeNewswire)
Mar-21-24 02:27PM	Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities Hagens Berman (GlobeNewswire)
Mar-20-24 07:00AM	Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q (GlobeNewswire)
Mar-14-24 12:30PM	Avid Bioservices (CDMO) Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of $146 Million of 2026 Notes as Long-Term Liabilities Hagens Berman (GlobeNewswire)
Mar-11-24 07:08PM	Avid Bioservices (CDMO) Tanks 30% After Disclosing Possible Accounting Restatements Due to $146 Million Acceleration Notice Hagens Berman (GlobeNewswire)
Mar-10-24 09:01PM	Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results (GuruFocus.com)
Mar-07-24 02:59PM	Attention Avid Bioservices Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire) -30.60%
09:05AM	Why Is Avid Bioservices (CDMO) Stock Down 30% Today? (InvestorPlace)
Mar-06-24 11:58PM	Avid Bioservices Announces Pricing of Private Placement of Convertible Notes (GlobeNewswire) +5.90%
04:32PM	Avid Bioservices Announces Proposed Private Placement of Convertible Notes (GlobeNewswire)
04:31PM	Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 (GlobeNewswire)
Jan-30-24 01:11AM	Avid Bioservices (CDMO) Declined in 2023 (Insider Monkey) -5.86%
Dec-19-23 05:01AM	Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc (GuruFocus.com) +15.38%
Dec-08-23 09:35AM	Why Is Avid Bioservices (CDMO) Stock Down 18% Today? (InvestorPlace) -12.29%
08:15AM	Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call Transcript (Insider Monkey)
Dec-07-23 09:54PM	CDMO Stock Earnings: Avid Bioservices Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
05:51PM	Avid Bioservices Inc (CDMO) Adjusts Fiscal 2024 Revenue Guidance Amidst Second Quarter Challenges (GuruFocus.com)
05:40PM	Avid Bioservices (CDMO) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:42PM	Avid Bioservices: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023 (GlobeNewswire)
Dec-01-23 06:16PM	Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) +8.71%
Nov-30-23 04:05PM	Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023 (GlobeNewswire)
Nov-28-23 09:35AM	Down -22.27% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround (Zacks)
Nov-15-23 04:02AM	Avid Bioservices (CDMO) Moves 9.0% Higher: Will This Strength Last? (Zacks)
Nov-08-23 08:05AM	Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs (GlobeNewswire) -6.30%
Oct-24-23 07:43AM	Does Avid Bioservices (CDMO) Have Potential For 200-400% Returns Over the Next Few Years? (Insider Monkey)
Oct-17-23 08:05AM	Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility (GlobeNewswire)
Sep-26-23 04:05PM	Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference (GlobeNewswire)
Sep-23-23 01:01AM	Insider Buying: Director Joseph Carleone Acquires 20,000 Shares of Avid Bioservices Inc (CDMO) (GuruFocus.com)
Sep-08-23 08:27AM	Avid Bioservices, Inc. (NASDAQ:CDMO) Q1 2024 Earnings Call Transcript (Insider Monkey) -6.84%
05:47AM	Q1 2024 Avid Bioservices Inc Earnings Call (Thomson Reuters StreetEvents)
Sep-07-23 05:40PM	Avid Bioservices (CDMO) Reports Break-Even Earnings for Q1 (Zacks)
04:28PM	Avid Bioservices: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023 (GlobeNewswire)
Aug-31-23 04:05PM	Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023 (GlobeNewswire) +5.93%
Aug-22-23 08:14AM	11 Most Undervalued Biotech Stocks to Buy According to Analysts (Insider Monkey)
Jul-31-23 05:14AM	Is Avid Bioservices (CDMO) a Volatile Stock? (Insider Monkey)
Jul-03-23 06:50AM	Daily Vickers Top Buyers & Sellers for 07/03/2023 (Argus Research)
Jun-23-23 10:05AM	Why Avid Bioservices Stock Was Plummeting This Week (Motley Fool)
Jun-22-23 03:36PM	Why Shares of Avid Bioservices Are Dropping Thursday (Motley Fool) -11.75%
12:10PM	Avid Bioservices, Accenture fall; Logitech, Steelcase rise, Thursday, 6/22/2023 (AP Finance)
06:03AM	Q4 2023 Avid Bioservices Inc Earnings Call (Thomson Reuters StreetEvents)
02:55AM	Dow futures slip ahead of Powell's reappearance; Amazon in focus (Investing.com)
Jun-21-23 08:00PM	CDMO: Lowering target price to $12.00 (Argus Research)
04:18PM	Avid Bioservices: Fiscal Q4 Earnings Snapshot (AP Finance)
04:07PM	Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023 (GlobeNewswire)
Jun-14-23 04:05PM	Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023 (GlobeNewswire)
Jun-08-23 07:37AM	Should You Invest in Avid Bioservices (CDMO)? (Insider Monkey)
07:30AM	What Makes Lifecore Biomedical (LFCR) an Attractive Investment Opportunity? (Insider Monkey)
Jun-04-23 08:03AM	Avid Bioservices (NASDAQ:CDMO) delivers shareholders enviable 37% CAGR over 5 years, surging 5.5% in the last week alone (Simply Wall St.)
May-30-23 05:48PM	15 Most Undervalued Growth Stocks To Buy According To Analysts (Insider Monkey)
May-22-23 03:15AM	Heres Why Artisan Partners Small Cap Fund Added Avid Bioservices (CDMO) to its Portfolio (Insider Monkey)
May-10-23 04:05PM	Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-08-23 06:12AM	Is There An Opportunity With Avid Bioservices, Inc.'s (NASDAQ:CDMO) 47% Undervaluation? (Simply Wall St.)
Apr-26-23 08:00PM	CDMO: Lowering target price to $14.00 (Argus Research)
Apr-24-23 03:41PM	Avid Bioservices Joins Elite Club Of Stocks With RS Ratings Over 90 (Investor's Business Daily)
Apr-17-23 08:17AM	Improved Earnings Required Before Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Find Their Feet (Simply Wall St.)
Apr-12-23 07:07AM	Daily Vickers Top Buyers & Sellers for 04/12/2023 (Argus Research)
Apr-04-23 08:05AM	Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers (GlobeNewswire)
Mar-14-23 12:35PM	Why Avid Bioservices Stock Is Surging Today (Motley Fool) +35.96%
11:20AM	Avid Bioservices, Inc. (NASDAQ:CDMO) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:22AM	Declining Stock and Solid Fundamentals: Is The Market Wrong About Avid Bioservices, Inc. (NASDAQ:CDMO)? (Simply Wall St.)
06:07AM	Q3 2023 Avid Bioservices Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-13-23 05:55PM	Avid Bioservices (CDMO) Q3 Earnings and Revenues Top Estimates (Zacks)

Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kwietniak Matthew R.	Chief Commercial Officer	Oct 14 '24	Sale	10.15	119	1,208	25,407	Oct 15 07:40 PM
Richieri Richard A.	Chief Operations Officer	Oct 10 '24	Sale	10.05	2,031	20,412	37,704	Oct 11 07:38 PM
Richieri Richard A.	Chief Operations Officer	Oct 10 '24	Sale	10.05	201	2,020	7,218	Oct 11 07:38 PM
Kwietniak Matthew R.	Chief Commercial Officer	Oct 10 '24	Sale	10.05	982	9,869	25,191	Oct 11 07:38 PM
Green Nicholas Stewart	President & CEO	Oct 10 '24	Sale	10.05	17,173	172,589	226,653	Oct 11 07:37 PM
Richard A. Richieri	Officer	Oct 10 '24	Proposed Sale	10.05	2,232	22,430		Oct 10 08:22 PM
Nicholas S. Green	Officer	Oct 10 '24	Proposed Sale	10.05	17,173	172,580		Oct 10 08:21 PM
Richieri Richard A.	Chief Operations Officer	Jul 15 '24	Sale	8.36	530	4,431	34,229	Jul 16 07:50 PM
Kwietniak Matthew R.	Chief Commercial Officer	Jul 15 '24	Sale	8.36	307	2,567	23,410	Jul 16 07:48 PM
Kwietniak Matthew R.	Chief Commercial Officer	Jul 12 '24	Sale	8.05	119	958	22,836	Jul 15 04:40 PM
Richieri Richard A.	Chief Operations Officer	Jul 11 '24	Sale	7.54	1,456	10,978	33,290	Jul 12 04:30 PM
Richieri Richard A.	Chief Operations Officer	Jul 11 '24	Sale	7.54	59	445	6,957	Jul 12 04:30 PM
Richieri Richard A.	Chief Operations Officer	Jul 10 '24	Sale	7.54	910	6,861	30,699	Jul 11 05:02 PM
Richieri Richard A.	Chief Operations Officer	Jul 10 '24	Sale	7.54	115	867	6,881	Jul 11 05:02 PM
Kwietniak Matthew R.	Chief Commercial Officer	Jul 10 '24	Sale	7.54	444	3,348	22,620	Jul 11 05:01 PM
Green Nicholas Stewart	President & CEO	Jul 10 '24	Sale	7.54	7,657	57,734	212,314	Jul 11 05:00 PM
Ziebell Mark R	V. P., General Counsel	Apr 30 '24	Sale	7.40	1,643	12,157	64,834	May 02 08:21 PM
Richieri Richard A.	Chief Operations Officer	Apr 30 '24	Sale	7.40	1,005	7,436	27,132	May 02 08:21 PM
Richieri Richard A.	Chief Operations Officer	Apr 30 '24	Sale	7.40	109	807	5,353	May 02 08:21 PM
Kwietniak Matthew R.	Chief Commercial Officer	Apr 30 '24	Sale	7.40	1,233	9,122	21,797	May 02 08:20 PM
Hart Daniel R	Chief Financial Officer	Apr 30 '24	Sale	7.40	2,826	20,910	82,221	May 02 08:20 PM
Green Nicholas Stewart	President & CEO	Apr 30 '24	Sale	7.40	11,762	87,028	203,606	May 02 08:20 PM
Kwietniak Matthew R.	Chief Commercial Officer	Jan 12 '24	Sale	6.77	274	1,855	19,829	Jan 12 07:34 PM
Ziebell Mark R	V. P., General Counsel	Jan 10 '24	Sale	6.17	1,346	8,305	63,269	Jan 11 07:39 PM
Richieri Richard A.	Chief Operations Officer	Jan 10 '24	Sale	6.17	1,055	6,509	25,625	Jan 11 07:38 PM
Richieri Richard A.	Chief Operations Officer	Jan 10 '24	Sale	6.17	116	716	5,208	Jan 11 07:38 PM
Kwietniak Matthew R.	Chief Commercial Officer	Jan 10 '24	Sale	6.17	1,060	6,540	19,434	Jan 11 07:37 PM
Hart Daniel R	Chief Financial Officer	Jan 10 '24	Sale	6.17	2,408	14,857	79,305	Jan 11 07:36 PM
Hancock Richard B	Director	Dec 13 '23	Buy	5.21	38,803	202,036	117,563	Jan 10 07:56 PM
Hancock Richard B	Director	Dec 15 '23	Buy	5.86	23,000	134,734	78,760	Dec 18 07:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDMO

Avid Bioservices Inc

Upgrade your FINVIZ experience